Title Why are some generic drugs skyrocketing in price? : hearing before the Subcommittee on Primary Health and Aging of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Thirteenth Congress, second session, on examining the pricing of generic drugs, November 20, 2014.

Publication Info.

Online access
Connect to https://purl.fdlp.gov/GPO/gpo81355

Item Status

Description	1 online resource (iii, 65 pages) : illustrations.
Physical Medium	monochrome
Description	text file
Series	S. hrg. ; 113-859
	United States. Congress. Senate. S. hrg. ; 113-859.
Note	Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
	CRDP Program record.
Bibliography	Includes bibliographical references.
Subject	Generic drugs -- Prices -- United States.
	Generic drugs -- Prices.
	United States.
	Generic drugs.
	Prescription pricing -- United States.
	Prescription pricing.
Genre/Form	Legislative hearings.
	Legislative hearings.
Other Form:	Print version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price? (DLC) 2017415497 (OCoLC)989729813
	Microfiche version: United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Primary Health and Aging. Why are some generic drugs skyrocketing in price? (OCoLC)1007740358
Gpo Item No.	1043-C (online)
Sudoc No.	Y 4.L 11/4:S.HRG.113-859